Our insights
By service
Not all pharma CSOs are created equal
Additional sales support can drive your brands to market success. This is where contract sales organisations come into play. However, not all CSOs offer the same level of value and expertise. So, how do you make the right choice?
Increasing prescribing with our combined skills
A pharma company with multiple brands across a range of therapy areas needed an increase in prescribing.
Patient identification resource
The patient identification resource (PIR) was required to accelerate patient access to the client’s brand. It was designed to support identification of patients suitable for the brand, following a promotional call, where a healthcare organisation had made the decision to optimise patient care using the brand.
Primary care sales: bespoke build and deployment
A global pharma-leader was looking to maintain and grow sales for a product 13 years into its lifecycle.
The impact of EU pharmaceutical reform
Uniphar was delighted to welcome European industry leaders to Zurich to debate the proposed EU pharmaceutical legislation reform, and incoming HTA reform. The conversation was held against the backdrop of the EU elections, and discussions focused on the impact of both on the pharma industry globally.
Reform of EU pharmaceutical legislation – where do we stand?
Unlock valuable insights and download our informative report
Europe’s decisive role in global healthcare’s future
As we look ahead to 2028, a confluence of factors will position Europe to play a decisive role in shaping the future of global healthcare. From policy leadership to research and development prowess, Europe's impact will be felt across many dimensions.
Realistic differentiation: Why unifying medical, early access, and commercial strategy is the only way forward in Europe
In today's healthcare landscape, biopharma is under immense pressure to differentiate every element of their products and services. With regulations continuously evolving and competition intensifying, traditional siloed approaches are no longer sufficient.
Go-to-Market Innovation in 2028: The essential disruption dimensions for thriving in the new European healthcare landscape
As we look ahead to 2028, the European healthcare market is poised for significant disruption.
The power of brand strategy for HCP customer engagement
In an increasingly competitive market, effectively engaging healthcare professionals is critical for building brand preference and driving prescribing behaviour. We unlock the power of brand strategy for customer engagement.
Supporting the patient doctor relationship – five top tips
Our last insight on this topic explored how patients have become more empowered as decision makers when it comes to their healthcare.
How the pharmacist has become a key decision maker
The role of the pharmacist in the pharma industry has evolved and their place in prescribing has accelerated. They are now key decision makers who need to be considered in pharma’s strategic approaches.
